Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/13/25 17:05 | 5/12/25 | GNLX | Health | Drug | Pharmaceutical Preparations | Ryder Sean | CA | O | GC | 1 | S | -13 | 2.92 | 0 | -4 | 48 | D | |||||||||||||||
5/13/25 17:05 | 5/12/25 | GNLX | Health | Drug | Pharmaceutical Preparations | Zindrick Thomas | CA | DO | P,CEO | 1 | S | -31 | 2.92 | 0 | -11 | 191 | D | |||||||||||||||
5/13/25 17:05 | 5/12/25 | GNLX | Health | Drug | Pharmaceutical Preparations | Yu Yong | CA | O | VP,Clini | 1 | S | -16 | 2.92 | 0 | -6 | 48 | D | |||||||||||||||
5/13/25 17:05 | 5/12/25 | GNLX | Health | Drug | Pharmaceutical Preparations | Cappello Joseph | CA | O | VP,Pharm | 1 | S | -14 | 2.92 | 0 | -5 | 52 | D | |||||||||||||||
5/13/25 17:05 | 5/12/25 | GNLX | Health | Drug | Pharmaceutical Preparations | Smalling Ralph | CA | O | Head of | 1 | S | -4 | 2.92 | 0 | -1 | 35 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |